Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. milking
Show results for
Products
Services
Software
Applications

Companies

News
Articles
Magazines
Downloads
Videos

Refine by
Date

  • Older

Milking Articles & Analysis

48 news found

H5N1 Antibodies and Antigens for Research Applications

H5N1 Antibodies and Antigens for Research Applications

In the spring of 2024, H5N1 2.3.4.4b clade viruses have also been detected in milk samples from cows and in raw milk in several states in the United States, causing significant global concern due to their serious impact on poultry and wildlife populations and potential risk to human health. ...

ByCreative Diagnostics


More than muscles: Sports nutrition evolves

More than muscles: Sports nutrition evolves

” Fonterra in 2022 conducted a project with athletes that found a liking for a powder containing whey protein isolates under the Fonterra brand NZMP (New Zealand Milk Products) and phospholipids under the Fonterra brand Nutiani. The whey protein isolates provided muscle health and strength. ...

ByNuritas Ltd.


Alnylam Announces FDA Approval of Supplemental New Drug Application for OXLUMO® (lumasiran) in Advanced Primary Hyperoxaluria Type 1

Alnylam Announces FDA Approval of Supplemental New Drug Application for OXLUMO® (lumasiran) in Advanced Primary Hyperoxaluria Type 1

- OXLUMO Now Indicated for the Treatment of Primary Hyperoxaluria Type 1 (PH1) to Lower Urinary and Plasma Oxalate Levels in Pediatric and Adult Patients - - Approval is Based on Positive Efficacy and Safety Results of the ILLUMINATE-C Phase 3 Study of OXLUMO in PH1 Patients with Severe Renal Impairment, Including Those on Hemodialysis - CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oct. 6, 2022-- Alnylam ...

ByAlnylam Pharmaceuticals, Inc.


PreludeDx Presents New DCISionRT Data on the Effectiveness of Endocrine Therapy in DCIS Patients at the ASCO 2022 Annual Meeting

PreludeDx Presents New DCISionRT Data on the Effectiveness of Endocrine Therapy in DCIS Patients at the ASCO 2022 Annual Meeting

Patients with DCIS have cancerous cells lining the milk ducts of the breast, but they have not spread into surrounding breast tissue. ...

ByPreludeDx


Annual General Meeting of Infant Bacterial Therapeutics

Annual General Meeting of Infant Bacterial Therapeutics

IBP-9414 contains the active compound Lactobacillus reuteri, which is a human bacterial strain naturally present in breast milk. The product portfolio also includes another project, IBP-1016, for the treatment of gastroschisis, a severe and rare disease affecting infants. ...

ByInfant Bacterial Therapeutics AB


The Essential Guide to Food Allergies

The Essential Guide to Food Allergies

Below are listed the most common types of food allergies: Milk: Cow’s milk is the most common milk source that causes allergy. ...

ByHYCOR Biomedical


PreludeDx to Present DCIS Study Results Assessing Benefit of Adjuvant Endocrine Therapy Using DCISionRT During Oral Presentation at ASCO 2022 Annual Meeting

PreludeDx to Present DCIS Study Results Assessing Benefit of Adjuvant Endocrine Therapy Using DCISionRT During Oral Presentation at ASCO 2022 Annual Meeting

Patients with DCIS have cancerous cells lining the milk ducts of the breast, but they have not spread into surrounding breast tissue. ...

ByPreludeDx


Fecal biomarkers - diagnostic possibilities in the context of inflammatory bowel disease

Fecal biomarkers - diagnostic possibilities in the context of inflammatory bowel disease

Lactoferrin is an iron-binding glycoprotein of about 80 kDa, which is mainly found in saliva, tear fluid or breast milk. Like calprotectin, lactoferrin is produced in neutrophilic granulocytes. ...

ByImmundiagnostik AG


Hidden Allergens in Christmas meals

Hidden Allergens in Christmas meals

Additionally, we can find other hidden allergens in beverages, such as pine nuts in craft beer, almonds in some gins, milk in cream liquors, or wheat in beers and spirits. Patients and clinicians must be educated about allergens' relevant sources and cross-reactive allergens to prevent accidental reactions. ...

ByHYCOR Biomedical


FDA Accepts Dupixent (dupilumab) for Priority Review in Patients Aged 12 Years and Older with Eosinophilic Esophagitis

FDA Accepts Dupixent (dupilumab) for Priority Review in Patients Aged 12 Years and Older with Eosinophilic Esophagitis

It is not known whether DUPIXENT passes into your breast milk. Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins and herbal supplements. ...

ByRegeneron Pharmaceuticals Inc.


Dupixent (dupilumab) Approved by European Commission for Children Aged 6 to 11 Years with Severe Asthma with Type 2 Inflammation

Dupixent (dupilumab) Approved by European Commission for Children Aged 6 to 11 Years with Severe Asthma with Type 2 Inflammation

It is not known whether DUPIXENT passes into your breast milk. Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins and herbal supplements. ...

ByRegeneron Pharmaceuticals Inc.


PreludeDx Presents Compelling DCISionRT Study Results in Young and High-Grade DCIS Patients at ASBrS 2022 Annual Meeting

PreludeDx Presents Compelling DCISionRT Study Results in Young and High-Grade DCIS Patients at ASBrS 2022 Annual Meeting

Patients with DCIS have cancerous cells lining the milk ducts of the breast, but they have not spread into surrounding breast tissue. ...

ByPreludeDx


Infant Bacterial Therapeutics publishes Annual Report for 2021

Infant Bacterial Therapeutics publishes Annual Report for 2021

IBP-9414 contains the active compound Lactobacillus reuteri, which is a human bacterial strain naturally present in breast milk. The product portfolio also includes another project, IBP-1016, for the treatment of gastroschisis, a severe and rare disease affecting infants. ...

ByInfant Bacterial Therapeutics AB


CD BioGlyco Introduces HMOs Separation Service for Glycobiology Study

CD BioGlyco Introduces HMOs Separation Service for Glycobiology Study

CD BioGlyco, a biotechnology company that provides a full range of glycobiology-related products, analysis, custom synthesis and design to customers worldwide, recently introduced its HMOs separation and analysis services for the healthcare industry. Human milk is the best food for newborns and developing infants, and its unique function is irreplaceable by other dairy ...

ByCD BioGlyco.


PreludeDx Closes $20 Million in Funding to Advance Growth Initiatives and Development of Its Precision Medicine Portfolio

PreludeDx Closes $20 Million in Funding to Advance Growth Initiatives and Development of Its Precision Medicine Portfolio

Patients with DCIS have cancerous cells lining the milk ducts of the breast, but they have not spread into surrounding breast tissue. ...

ByPreludeDx


PreludeDx Presents DCIS Patient Data Comparing Clinicopathological Risk Factors to DCISionRT

PreludeDx Presents DCIS Patient Data Comparing Clinicopathological Risk Factors to DCISionRT

Patients with DCIS have cancerous cells lining the milk ducts of the breast, but they have not spread into surrounding breast tissue. ...

ByPreludeDx


UroGen Announces Data that Shows In-Office Nephrostomy Tube Administration of Jelmyto® is Efficient for Doctors and Well Tolerated by Patients

UroGen Announces Data that Shows In-Office Nephrostomy Tube Administration of Jelmyto® is Efficient for Doctors and Well Tolerated by Patients

It is not known if JELMYTO passes into your breast milk. Do not breastfeed during treatment with JELMYTO and for 1 week after the last dose. ...

ByUroGen Pharma, Inc.


PreludeDx DCISionRT Predicts Radiation Benefit in Landmark Randomized SweDCIS Clinical Trial

PreludeDx DCISionRT Predicts Radiation Benefit in Landmark Randomized SweDCIS Clinical Trial

Patients with DCIS have cancerous cells lining the milk ducts of the breast, but they have not spread into surrounding breast tissue. ...

ByPreludeDx


Successful development and approval of Skinatan® 1 mg/g Emulsion – a new generic drug for the treatment of inflammations and allergic reactions

Successful development and approval of Skinatan® 1 mg/g Emulsion – a new generic drug for the treatment of inflammations and allergic reactions

Skinatan 1 mg/g Emulsion is a dermatological milk for cutaneous use with the active ingredient methylprednisolone aceponate (MPA). ...

ByAresus Pharma GmbH


Recruitment of the smallest infants in the Connection study paused

Recruitment of the smallest infants in the Connection study paused

IBP-9414 contains the active compound Lactobacillus reuteri, which is a human bacterial strain naturally present in breast milk. The product portfolio also includes another project, IBP-1016, for the treatment of gastroschisis, a severe and rare disease affecting infants. ...

ByInfant Bacterial Therapeutics AB

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT